je.st
news
OncoSec Medical Incorporated: The Best Immuno-Oncology Biotech You've Never Heard Of
2015-06-25 06:21:30| Biotech - Topix.net
Newly uplisted, small cap biotech OncoSec is making big advancements in the immuno-oncology space with its unique ImmunoPulse intratumor delivery technology. OncoSec has a market cap of only ~$100M, over $30M in cash, several Phase 2 clinical trials underway, impressive clinical data and the potential to revolutionize immuno-oncology treatment.
Tags: of
medical
heard
incorporated
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||